DREXLER RYAN CHARLES (CEO) reported 2 transactions at MUSCLEPHARM CORP
Review the transaction codes below to understand the nature of each event.
Filed: 9/20/2019ACC: 0001654954-19-010955
DirectorOfficer· CEO
Since Jan 2018
+16.30M
Net shares
Net buyer
$18.05M
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
16.30M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+81.11K
Price / share
$0.65
Trade value
$52.72K
% of position
13.9%
1/5/2018
581.92K→663.04K
Common Stock
Direct
Shares
+16.22M
Price / share
$1.11
Trade value
$18M
% of position
2445.7%
9/16/2019
663.04K→16.88M
Total
Net shares
+16.30M
Net value
$18.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2018 | J · J | +81.11K | $0.65 | $52.72K | 13.9% | 581.92K | 663.04K |
| Common Stock Direct | 9/16/2019 | C · Conversion | +16.22M | $1.11 | $18M | 2445.7% | 663.04K | 16.88M |
| Total | +16.30M | $18.05M | ||||||
Derivative Transactions1
Convertible Promissory Note (right to buy)
Direct
Converts to
Common Stock
16.22M shares
Shares
−0.00
Strike price
1.11
Held after
0.00
Exercisable
—
9/16/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Promissory Note (right to buy) Direct | Common Stock16.22M shares | 9/16/2019 | C · Conversion | −0.00 | 1.11 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.50M
Total
1.50M indirect1.50M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.50M | Indirect |
| Total | 1.50M | 1.50M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported